Finance

Lists
Q2 2026 earnings
See results
EPRX:TSE
Eupraxia Pharmaceuticals Inc
CA$9.09
-2.78%
(-0.26) 1D
Aug 12, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for EPRX...
Open
CA$9.36
High
CA$9.44
Low
CA$8.91
Mkt. cap
590.34M
Avg. vol.
62.79K
Volume
69.24K
52-wk high
CA$12.86
52-wk low
CA$6.94
EPS
-CA$1.34
Beta
1.11
Shares outstanding
65.33M
No. of employees
49
Open
CA$9.36
High
CA$9.44
Low
CA$8.91
Mkt. cap
590.34M
Avg. vol.
62.79K
Volume
69.24K
52-wk high
CA$12.86
52-wk low
CA$6.94
EPS
-CA$1.34
Beta
1.11
Shares outstanding
65.33M
No. of employees
49
News stories
From web sources and news partners
About Eupraxia Pharmaceuticals Inc
CEO-
Employees49
Founded2011
HeadquartersVictoria, British Columbia, Canada
SectorBiotechnology
Websiteeupraxiapharma.com
Last report
Aug 11, 2026
Fiscal period
Q2 2026
EPS / Est. (CAD)
-CA$0.32 / -
Revenue / Est. (CAD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.20M
4.42M
7.87M
11.17M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.07M
2.47M
8.30M
4.78M
Operating expense
8.26M
6.88M
16.16M
15.96M
Total operating expenses
8.26M
6.88M
16.16M
15.96M
Operating income
-8.26M
-6.88M
-16.16M
-15.96M
Other non operating income
-
-
-
-
EBT including unusual items
-8.74M
-6.37M
-16.71M
-12.64M
EBT excluding unusual items
-8.74M
-6.37M
-16.71M
-12.64M
Income tax expense
5.58K
-623.00
11.34K
13.90K
Effective tax rate
-0.06%
0.01%
-0.07%
-0.11%
Other operating expenses
-
-
-
-
Net income
-8.74M
-6.36M
-16.71M
-12.65M
Net profit margin
-
-
-
-
Earnings per share
-
-0.19
-
-
Interest and investment income
255.96K
180.18K
666.92K
1.07M
Interest expense
-
-
-
-
Net interest expenses
255.96K
180.18K
666.92K
1.07M
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.23M
-6.84M
-16.11M
-15.90M
Gain or loss from assets sale
-
-
1.49K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps